PRDM1 and breast cancer: In contrast, in breast cancer cells TGF-β1 induces Blimp-1 expression via a c-Raf/ERK/AP-1 pathway and Blimp-1 mediates TGF-β-induced EMT via repression of BMP-5 (Romagnoli et al., 2012).